Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
health published : Today save search
The Gross Law Firm Reminds agilon health, inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - AGL
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
VTYX | $4.44 2.07% 310K
|
Manufacturing
|
| O: -0.68%
H: 0.0%
C: 0.0%
INVZ | News | $1.03 -2.83% 730K
|
|
| O: -2.78%
H: 0.0%
C: 0.0%
deadline
Shareholders that lost money on SSR Mining Inc.(SSRM) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
DKS | $192.91 -1.18% 170K
|
Retail Trade
|
| O: -0.7%
H: 0.0%
C: 0.0%
SSRM | News | $5.34 3.89% 1.3M
|
Non-Energy Minerals
|
| O: -0.58%
H: 0.0%
C: 0.0%
AVXL | $3.63 -4.47% 860K
|
Health Technology
|
| O: -8.11%
H: 0.0%
C: 0.0%
mining
Class Action Filed Against iRobot Corporation (IRBT) Seeking Recovery for Investors - Contact The Gross Law Firm
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
EVLV | $3.84 -2.54% 500K
|
|
| O: 3.43%
H: 0.0%
C: 0.0%
IRBT | $7.15 -1.38% 540K
|
Consumer Durables
|
| O: 7.19%
H: 0.0%
C: 0.0%
IESC | $115.175 -0.6% 23K
|
Industrial Services
|
| O: -1.33%
H: 0.0%
C: 0.0%
AVXL | $3.63 -4.47% 860K
|
Health Technology
|
| O: -8.11%
H: 0.0%
C: 0.0%
corporation for
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | $13.45 4.34% 170K
|
n/a
|
| O: 4.19%
H: 0.0%
C: 0.0%
KMDA | $5.21 2.16% 19K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
humira biosimilar approved for agreement
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
PRQR | $2.0 7.53% 96K
|
Health Technology
|
| O: 3.13%
H: 0.0%
C: 0.0%
defense
Todays' Top-5
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
TLSA | News | $0.66 3.13% 420K
|
Health Technology
|
| O: 20.07%
H: 0.0%
C: 0.0%
today anti-cd3 life neurology foralumab sclerosis sciences results study
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MIRM | $23.7 0.55% 110K
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: 0.0%
report million reach treatment market
Addex to Present at the Swiss Biotech Day 2024
Published: 2024-04-19 (Crawled : 05:00) - globenewswire.com
ADXN | News | $18.3 -12.69% 11K
|
Health Technology
|
| O: -20.4%
H: 0.0%
C: 0.0%
day biotech
How retailers and “payviders” are disrupting U.S. healthcare in 2024
Published: 2024-04-19 (Crawled : 08:00) - clarivate.com
LHCG | $169.81 0.47% -0.03% 0
|
Health Services
| Email alert
Add to watchlist
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
OM | $2.3 2.22% 340K
|
Health Technology
|
| O: 2.78%
H: 0.0%
C: 0.0%
first report medical financial results
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectati...
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
miss
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
SBFM | $1.84 -44.58% 9M
|
Professional, Scientific, and T...
|
| O: -65.59%
H: 0.0%
C: 0.0%
pharma biosimilar health approval for canada
Concord Medical Files 2023 Annual Report on Form 20-F
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
CCM | $0.5001 -14.25% 800
|
Health Services
| Email alert
Add to watchlist
report medical
GL Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Globe Life Inc. (GL) Investors to Contact the Firm
Published: 2024-04-19 (Crawled : 14:00) - prnewswire.com
ZTS | News | $147.61 -3.59% 2.5M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
GL | News | $66.77 2.72% 1.2M
|
Finance
|
| O: 2.07%
H: 0.0%
C: 0.0%
life
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
first treatment for
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma management for
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
Published: 2024-04-19 (Crawled : 13:00) - globenewswire.com
CRMD | $5.325 -1.75% 1.4M
|
Health Technology
|
| O: 3.14%
H: 0.0%
C: 0.0%
defencath grants
White River Bancshares Co. Earns $509,000, or $0.51 Per Diluted Share, in First Quarter 2024; Highlighted by Higher Net Interest Income and Double Digit Loan and Deposit Growth Year-Over-Year
Published: 2024-04-19 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
first growth
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
RPRX | $28.06 0.61% 460K
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
first pharma royalty financial results
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.